MEDEQUIP GROUP LIMITED

Company number 09553385 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Risk Rating: MEDIUM

Justification: The company is active, not in insolvency proceedings, and its statutory filings are not overdue. However, the available data contains no balance sheet, profit and loss, or cash flow figures, so solvency and liquidity cannot be quantitatively assessed. The combination of missing financial data, a recent director resignation, and audit-exemption subsidiary status supports a medium risk rating pending review of the underlying accounts.

Key Concerns

  1. No financial performance or position data provided: The dataset confirms that accounts were made up to 31 December 2025 and are not overdue, but it includes no figures for fixed assets, current assets, current liabilities, net assets, or profitability. Without these figures, it is not possible to determine whether the company can meet its obligations or whether there are cash flow warning signs.

  2. Recent board change: One director resigned on 3 July 2026. The available data does not state the reason for the departure, and the timing—shortly after the latest accounts date—warrants verification as part of governance due diligence.

  3. Group structure and audit exemption: The company is categorised as an audit-exemption subsidiary. A corporate entity holds more than 75% of the shares and voting rights and has the right to appoint and remove directors. This concentration of ownership, together with the audit exemption, limits standalone financial transparency and may indicate dependence on group-level support or guarantees.

Positive Indicators

  • Active company status with no indication of liquidation, administration, or receivership.
  • Incorporated in April 2015, indicating approximately ten years of continuous registration.
  • Accounts and confirmation statement filings are current and not overdue.
  • Share capital of approximately £375,000.
  • Majority corporate shareholder may provide access to group resources and financial backing.

Due Diligence Notes

  • Obtain the latest filed annual accounts (made up to 31 December 2025) to assess net assets, working capital, cash holdings, creditor positions, and trading results.
  • Clarify the accounting reference date and filing timeline, as the period between the last accounts date and the next due date appears longer than the standard nine-month private company deadline.
  • Investigate the circumstances of the director resignation in July 2026 and confirm whether the board remains appropriately constituted.
  • Review the financial strength of the parent company, Medequip Holdings Limited, and any parental guarantees, cross-company obligations, or group banking arrangements.
  • Confirm whether any contingent liabilities, asset charges, or security over the company’s assets exist.

Perspective: Investment Risk Assessor · Model: nvidia/nemotron-3.5-super-vl:free · Generated 14 November 2026